Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2025-12-25 @ 11:24 PM
NCT ID: NCT03695393
Description: None
Frequency Threshold: 0
Time Frame: Adverse event data were collected over the course of the 6-month study period.
Study: NCT03695393
Study Brief: Stigma, Risk Behaviors and Health Care Among HIV-infected Russian People Who Inject Drugs
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Intervention- ACT Therapy Participants randomized to this group will receive three ACT sessions over 1 month ACT Therapy: The ACT intervention will consist of three 2-hour group sessions of culturally adapted ACT (intervention) to reduce stigma and related manifestations.Participants are recruited from a civil society organization and all other study procedures take place at a rehabilitation center. The ACT sessions will be scheduled to take place at the rehabilitation center following randomization.The First St. Petersburg Pavlov State Medical University is an alternative location where sessions can be conducted. Sessions will be planned to occur in weekly succession, with a goal of 3 sessions within the first month of study participation. 3 None 5 67 2 67 View
Standard of Care Participants in the control group will receive standard care as normally provided to patients by civil society organizations. 1 None 1 33 0 33 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Hospitalization due to HIV progression NON_SYSTEMATIC_ASSESSMENT Immune system disorders None View
Hospitalization due to pulmonary tuberculosis NON_SYSTEMATIC_ASSESSMENT Infections and infestations None View
Death due to stroke NON_SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Death due to cerebral edema NON_SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Death due to cancer NON_SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
HIV progression NON_SYSTEMATIC_ASSESSMENT Immune system disorders None View
Pulmonary tuberculosis NON_SYSTEMATIC_ASSESSMENT Infections and infestations None View